Xiuying Xiao
Papers
1
Total Citations
3
H-Index
1
About
Dr. Xiuying Xiao is a leading authority in the diagnosis and treatment of pancreatic neuroendocrine neoplasms (pNENs), a rare and highly heterogeneous group of tumors that account for roughly 3% of all pancreatic malignancies. Her most impactful work includes spearheading the *Chinese Medical Association consensus for standardized diagnosis and treatment of pancreatic neuroendocrine neoplasms* (2023), a landmark guideline that has already garnered 3 citations and is shaping clinical practice across China. By addressing the rising global incidence of pNENs and their complex biological behavior, Dr. Xiao’s research bridges critical gaps in standardization—offering evidence-based protocols for managing these challenging tumors from pluripotent stem cell origins. Her contributions are particularly vital given the field’s rapid evolution, and her consensus document serves as a cornerstone for clinicians and researchers alike. With a career dedicated to improving outcomes for patients with neuroendocrine malignancies, Dr. Xiao continues to drive progress in precision oncology, ensuring that rare tumor subtypes receive the rigorous, standardized care they demand. Her work exemplifies the power of collaborative medical consensus in advancing rare disease management.
Research Focus
Key Achievements
Top Papers
- 1